Different MRI patterns in MS worsening after stopping fingolimod
Caterina Lapucci(Université de Bordeaux), Luca Roccatagliata(Martin University), Damiano Baroncini, Maria Cellerino(Ospedale Policlinico San Martino), Ilaria Callegari(MACOM (United States)), Antonio Uccelli(Istituti di Ricovero e Cura a Carattere Scientifico), Giacomo Boffa(Centre National de la Recherche Scientifique), Maria Pia Sormani(University of Genoa), Matilde Inglese(New York University), Giovanni Novi(MACOM (United States)), Mauro Zaffaroni(Associazione Italiana Sclerosi Multipla), Matteo Pardini(University of Genoa), Angelo Ghezzi
Cited by 26
Related Papers
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis
|Multiple Sclerosis Journal|2018|706
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Biallelic expansion of an intronic repeat in RFC1 is a common cause of late-onset ataxia
|Nature Genetics|2019|592